Top phar­ma­ceu­ti­cal trade groups say the FDA will have a ded­i­cat­ed pool of mon­ey to re­plen­ish its sta­ble of re­view­ers as part of the new...

Vi­a­tris, a gener­ics and brand­ed med­i­cines mak­er, is buy­ing in­to non-opi­oid pain drugs with a cash ac­qui­si­tion of com­mer­cial-stage Paci­ra Bio­Sciences.

The Thurs­day morn­ing deal, val­ued at...

Ar­genx on Thurs­day re­port­ed one suc­cess and one set­back in its au­toim­mune dis­ease pipeline, send­ing its shares tum­bling.

The Bel­gian-Dutch phar­ma saidit is shut­ter­ing...

Zealand Phar­ma and Roche rolled out some mid-stage da­ta for their amylin drug in obe­si­ty and di­a­betes, hop­ing to com­pete with Eli Lil­ly.

In a...

A preg­nan­cy-re­lat­ed hy­per­ten­sion dis­or­der that im­pacts mil­lions of moth­ers and new­borns each year is get­ting more at­ten­tion from the top lev­els of pub­lic health or­ga­ni­za­tions...